Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Gossamer Bio, Inc. - Common Stock (NQ:GOSS)

0.1994 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Jul 27, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	29,926,639
Open	0.1994
Bid (Size)	0.2744 (5,000)
Ask (Size)	0.2757 (300)
Prev. Close	0.1994
Today's Range	0.1994 - 0.1994
52wk Range	0.1138 - 3.870
Shares Outstanding	75,993,532
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

12 Health Care Stocks Moving In Monday's After-Market Session ↗

July 27, 2026

Gainers Gossamer Bio (NASDAQ:GOSS) shares rose 28.8% to $0.26 during Monday's after-market session. The company's market cap stands at $66.4 million. ProMIS Neurosciences (NASDAQ:PMN) shares increased...

Via Benzinga

Top movers in Monday's after hours session ↗

July 27, 2026

Via Chartmill

Performance

YTD	-93.1%	-93.1%
1 Month	+21.6%	+21.6%
3 Month	-42.8%	-42.8%
6 Month	-92.5%	-92.5%
1 Year	-89.9%	-89.9%

More News

Which stocks are moving on Monday? ↗

July 27, 2026

Via Chartmill

Curious about the most active stocks on Monday? ↗

July 27, 2026

Via Chartmill

12 Health Care Stocks Moving In Monday's Intraday Session ↗

July 27, 2026

Via Benzinga

Monday's session: top gainers and losers ↗

July 27, 2026

Via Chartmill

These stocks that are showing activity before the opening bell on Monday. ↗

July 27, 2026

Via Chartmill

Gossamer Bio Announces FDA Regulatory Update and Reacquisition of Worldwide Rights Related to Seralutinib and Provides a Business Update

July 27, 2026

From Gossamer Bio, Inc.

Via Business Wire

Top movers in Monday's after hours session ↗

July 20, 2026

Via Chartmill

Gossamer Bio, Inc. Announces Determination of Conversion Rate for 7.50% Convertible Senior Secured First Lien Notes due 2030 and Exercise Price for Purchase Warrants

July 01, 2026

From Gossamer Bio, Inc.

Via Business Wire

Wondering what's happening in today's after-hours session? ↗

June 29, 2026

Via Chartmill

Gossamer Bio, Inc. Announces Final Tender Results for Exchange Offer and Consent Solicitation with Respect to Existing Convertible Notes

June 17, 2026

From Gossamer Bio, Inc.

Via Business Wire

Gossamer Bio, Inc. Announces Early Tender Results and Early Settlement for Exchange Offer and Consent Solicitation with Respect to Existing Convertible Notes

June 03, 2026

From Gossamer Bio, Inc.

Via Business Wire

CLASS ACTION DEADLINE TONIGHT: Gossamer Bio (GOSS) Investors Who Suffered Losses Encouraged to Contact Faruqi & Faruqi Before June 1, 2026 Securities Class Action Deadline

June 01, 2026

From Faruqi & Faruqi, LLP

Via Business Wire

GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm

June 01, 2026

From The Schall Law Firm

Via Business Wire

Gossamer Bio, Inc. Announces Extension of Early Tender Date for Exchange Offer and Consent Solicitation with Respect to Existing Convertible Notes

June 02, 2026

From Gossamer Bio, Inc.

Via Business Wire

GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm

May 31, 2026

From Schall Law

Via GlobeNewswire

GOSSAMER BIO DEADLINE MONDAY JUNE 1st: Bragar Eagel & Squire, P.C. Urges Gossamer Bio, Inc. (NASDAQ:GOSS) Investors with Large Losses to Contact the Firm Before Monday June 1st

May 29, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

Deadline Soon: Gossamer Bio, Inc. (GOSS) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

May 29, 2026

From The Law Offices of Frank R. Cruz

Via Business Wire

GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm

May 28, 2026

From Schall Law

Via GlobeNewswire

GOSSAMER DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Gossamer Bio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – GOSS

May 27, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

Gossamer Bio (GOSS) Q1 2026 Earnings Transcript ↗

May 27, 2026

Via The Motley Fool

Bragar Eagel & Squire, P.C. Urges Gossamer Bio, Inc. (NASDAQ:GOSS) Investors with Large Losses to Contact the Firm Before Monday June 1st

May 26, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Gossamer Bio, Inc. of Class Action Lawsuit and Upcoming Deadlines – GOSS

May 26, 2026

From Pomerantz LLP

Via GlobeNewswire

DEADLINE APPROACHING: Berger Montague Advises Gossamer Bio, Inc. (NASDAQ: GOSS) Investors to Inquire About a Securities Fraud Class Action by June 1, 2026

May 26, 2026

From Berger Montague

Via GlobeNewswire

Frequently Asked Questions

Is Gossamer Bio, Inc. - Common Stock publicly traded?

Yes, Gossamer Bio, Inc. - Common Stock is publicly traded.

What exchange does Gossamer Bio, Inc. - Common Stock trade on?

Gossamer Bio, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Gossamer Bio, Inc. - Common Stock?

The ticker symbol for Gossamer Bio, Inc. - Common Stock is GOSS on the Nasdaq Stock Market

What is the current price of Gossamer Bio, Inc. - Common Stock?

The current price of Gossamer Bio, Inc. - Common Stock is 0.1994

When was Gossamer Bio, Inc. - Common Stock last traded?

The last trade of Gossamer Bio, Inc. - Common Stock was at 07/27/26 04:00 PM ET

What is the market capitalization of Gossamer Bio, Inc. - Common Stock?

The market capitalization of Gossamer Bio, Inc. - Common Stock is 15.15M

How many shares of Gossamer Bio, Inc. - Common Stock are outstanding?

Gossamer Bio, Inc. - Common Stock has 15M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.